Categories
Medical Articles

Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels

Jarred Younger, Noorulain Noor, Rebecca McCue, Sean Mackey

https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.37734

Conclusion: The preliminary evidence continues to show that low-dose naltrexone has a specific and clinically beneficial impact on fibromyalgia pain. The medication is widely available, inexpensive, safe, and well-tolerated. Parallel-group randomized controlled trials are needed to fully determine the efficacy of the medication.

Leave a Reply

Your email address will not be published.